NCT06088069

Brief Summary

The aim of this study is to evaluate Virtual reality (VR) on perioperative anxiety, pain, hemodynamics, and stress hormones in patients undergoing Total hip arthroplasty (THA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 18, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

October 19, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 5, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

10 months

First QC Date

October 12, 2023

Last Update Submit

September 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anxiety

    Each patient will be instructed about the scores; State Anxiety Inventory (STAI-S). The Arabic validated version of STAI-S test will be provided to the patients to determine the anxiety levels. Scores vary between and 20-80 with high scores associated with higher anxiety levels. Patients will be asked to read each statement and then indicate how they were feeling at that moment by marking the appropriate parentheses on the right side of each statement. Anxiety will be measured at baseline (15 min before operation), before spinal anesthesia and immediately postoperative.

    15 min before operation till immediately postoperative.

Secondary Outcomes (8)

  • Total intraoperative haloperidol consumption

    Intraoperatively.

  • Stress measured by Cohen Perceived Stress Scale

    15 min before operation till immediately postoperative.

  • Stress measured by blood serum level of cortisol

    6 hours postoperative.

  • The degree of postoperative pain

    24 hours postoperatively.

  • Amount of opioid consumption

    24 hours after surgery.

  • +3 more secondary outcomes

Study Arms (2)

Group VR

EXPERIMENTAL

Patients will be virtually immersed into a natural universe and soft music for 15 minutes preoperatively and during surgery.

Other: Virtual reality

Group C

NO INTERVENTION

Patients will not receive Virtual reality (VR) experience.

Interventions

Patients will be virtually immersed into a natural universe and soft music for 15 minutes preoperatively and during surgery.

Group VR

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 21 years or above.
  • Both sexes.
  • The American Society of Anesthesiologists (ASA) physical status I-III.
  • Scheduled for elective THA under spinal anesthesia.

You may not qualify if:

  • Cerebrovascular disease.
  • Psychiatric-cognitive dysfunction.
  • Claustrophobia.
  • Deaf and blind patients.
  • Uncooperative.
  • Adrenal insufficiency.
  • Chronic alcohol and substance addiction.
  • Chronic sedative and narcotic use.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, El-Gharbia, 31527, Egypt

Location

Related Publications (1)

  • Moharam SA, ElSharkawy MS, ELkashef AM, Romeih MA, El Rasool AOAR, Shaheen MM. Effect of virtual reality on perioperative anxiety, stress and pain in total hip arthroplasty: a randomized controlled trial. BMC Anesthesiol. 2025 Sep 9;25(1):446. doi: 10.1186/s12871-025-03316-3.

MeSH Terms

Conditions

Anxiety DisordersPain

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine

Study Record Dates

First Submitted

October 12, 2023

First Posted

October 18, 2023

Study Start

October 19, 2023

Primary Completion

August 5, 2024

Study Completion

August 5, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations